Regeneron Pharmaceuticals, Inc. is a security (CUSIP 75886FAE7) tracked across SEC portfolio filings. 17 registered fund positions totaling $28.6M via N-PORT as of 2026-05-31.
Showing 15 of 17 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| Franklin Total Return Fund | Franklin Investors Securities Trust | $6.7M | 23.35% |
| Capital World Bond Fund | Capital World Bond Fund | $5.3M | 5.38% |
| BlackRock Balanced Fund, Inc. | BlackRock Balanced Fund, Inc. | $3.3M | 18.01% |
| American Funds Global Balanced Fund | American Funds Global Balanced Fund | $3.1M | 0.96% |
| Advantage CoreAlpha Bond Master Portfolio | Master Investment Portfolio II | $2.2M | 32.15% |
| Federated Hermes Corporate Bond Fund | Federated Hermes Investment Series Funds, Inc. | $1.2M | 12.44% |
| JPMorgan Core Bond Trust | JPMorgan Institutional Trust | $1.1M | 2.42% |
| GENERAL ELECTRIC RSP INCOME FUND | GENERAL ELECTRIC RSP INCOME FUND | $979K | 4.99% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $887K | 0.15% |
| VALUE LINE ASSET ALLOCATION FUND INC | VALUE LINE ASSET ALLOCATION FUND INC | $886K | 24.11% |
| Putnam Multi-Asset Income Fund | Putnam Asset Allocation Funds | $882K | 9.89% |
| BlackRock Balanced Portfolio | BlackRock Series Fund, Inc. | $824K | 17.71% |
| VALUE LINE CAPITAL APPRECIATION FUND INC | VALUE LINE CAPITAL APPRECIATION FUND INC | $665K | 14.40% |
| PF Managed Bond Fund | Pacific Funds Series Trust | $486K | 13.28% |
| VALUE LINE CORE BOND FUND | Value Line Core Bond Fund | $132K | 38.09% |